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Abstract: Preterm babies are born with an immature intestine and are at higher risk for intestinal failure and needing for 
parenteral nutrition than full-term newborns. These babies show an altered intestinal microbiota, which may results of 
key importance for later health. However, there is a lack of information on effect of parenteral formulas upon the 
establishing infant microbiota. Moreover, the microbiota alterations present in preterm newborns have been related with 
an altered redox-potential which hinders the establishment of strict anaerobes. Thus, interventions aimed at reducing the 
oxidative stress in these infants, including those under parenteral nutrition, could also affect the intestinal microbiota 
composition. We assessed the effect upon the gut microbiota of the administration during 30 days of a lipid emulsion, 
containing ?3 polyunsaturated fatty acids and ?-tocopherol, or a control emulsion containing soybean-bases lipids to 
parenterally-fed preterm newborns. In spite of its high antioxidant potential, the infants receiving the experimental fat 
emulsion showed a trend to increase of facultative anaerobes such as enterobacteria and specifically of Klebsiella. This 
study stresses the need of further work monitoring the impact of early-life parenteral nutrition on the establishment of the 
intestinal microbiota. 
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INTRODUCTION 
The basis for a healthy intestinal microbiota lies in 
the early neonatal period with the initial steps of the 
microbiota establishment [1]. In healthy infants the 
process starts with facultative anaerobes which reduce 
oxygen level allowing the establishment of strict 
anaerobic microbial populations [2]. During this 
relatively unstable and sensitive initial period any 
aberrancy in the microbiota development process may 
entail a high-risk of disease for later life [1, 3]. Different 
factors influence the early establishment of the gut 
microbiota, and its further development, including 
gestational age, mode of delivery, antibiotic use or 
feeding habits, among others [3-5].  
At birth the neonate is changed from a hypoxic fetal 
environment to a hyperoxic environment which causes 
oxidative stress and concomitant damage by reactive 
oxygen species. Preterm infants are born with an 
immature intestinal mucosa, which represents a risk for 
intestinal failure, and have been reported to have 
problems for properly managingoxidative stress due to 
their immature antioxidant systems [6]. This limited 
ability to manage the oxidative stress has been linked 
to the increased risk of the premature baby to suffer the  
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so called “free radical-related diseases”, such as 
retinopathy, bronchopulmonary dysplasia and necro-
tizing enterocolitis. For these reasons the supplemen-
tation of preterm babies diet with antioxidants has 
attracted the attention of researchers [7].  
Recent data obtained from microbial culture-
independent techniques have identified clear 
alterations in the process of intestinal microbiota 
establishment in preterms when compared with that of 
full-term babies. In general preterm infants harbor 
higher levels of facultative anaerobes and reduced 
levels of strict anaerobes [4]. These observations 
suggest a deficiency in the development of a low 
redox-potential in the intestinal environment, which 
limits the establishment of the anaerobic gut microbiota 
in these babies. This has led to the hypothesis that the 
different microbiotas observed between preterm and 
full-term babies may be, at least partly, due to an 
altered intestinal redox environment [8]. Indeed, the 
redox potential has been reported as one of the major 
intestinal factors driving the microbiota composition [9]. 
Therefore, preterm infants would benefit from the 
development of strategies favoring the establishment of 
a healthy microbiota. 
Moreover, in some cases, due to intestinal failure, 
the enteral feeding of the infant is not possible and 
parenteral nutrition (PN) is needed. In spite of its 
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important role for later health, little is known about the 
impact of PN upon the establishing gut microbiota. 
Animal studies in a PN associated liver injury model 
reported changes in the microbiota composition under 
different PN solutions [10]. However, the information on 
the impact of PN formulas on the preterm newborn 
microbiota is largely lacking.  
This study aims at exploring the effect of PN upon 
the establishing gut microbiota in a group of preterm 
infants and to evaluate the impact of an antioxidant PN 
formula upon this process.  
SUBJECTS AND METHODS 
Twenty-five infants born at the “IASO” Maternity 
Hospital in Athens with gestational age < 32 weeks, 
birth weight < 1500 g, at least 80% of total energy 
intake as PN and admitted to the Neonatal Intensive-
Care Unit (NICU) were included in the study. Infants 
with liver or bile duct disease were excluded from the 
study. The subjects participating in this work are a 
subset of a larger ongoing intervention study. The 
study was approved by the Scientific and Ethical 
Committee of the IASO Maternity Hospital. 
At admission infants were randomly assigned to 
groups receiving either an ?3 polyunsaturated fatty 
acids containing formula supplemented with tocopherol 
(SMOFLipid 20%, Fresenius Kabi HELLAS, Athens, 
Greece; medium-chain triglycerides [30%], lipids from 
soybean oil ([0%], olive oil [25%], fish oil [15%] ?-
tocopherol [0.2 mg/mL]) (intervention group, n=8) or a 
control emulsion containing soybean-based lipids 
(INTRALipid 20%, Fresenius Kabi HELLAS, Athens, 
Greece) (control group, n=17) [7]. Infants started the 
PN from the first day of life, lipid emulsions (LE) were 
added in the PN solution from the second day of life. 
For all infants, PN regimens were designed and 
automatically produced as described previously [11]. 
Macronutrients were provided using the same products 
for glucose and amino acid solutions in both groups.  
Fresh fecal samples were collected and 
immediately frozen at -20ºC until analyses. We 
monitored the fecal levels of seven intestinal microbial 
groups (Bacteroidaceae, Bifidobacteriaceae, 
Enterobacteriaceae, Enterococcaceae, Lactobacillus 
group and the genera Klebsiella and Weissella), as well 
as fecal short-chain fatty acids (SCFA) profile, during 
30 days of administration to preterm infants of a 
parenteral LE. Bacterial levels of the different microbial 
groups were analyzed by quantitative PCR and SCFA 
concentrations were determined in fecal samples as 
previously described [4]. 
RESULTS  
The results obtained showed a high inter-individual 
variability in both bacterial levels (Figure 1) and SCFA 
concentration (Figure 2) and were in the range of those 
normally observed for preterm infants [4, 5] with the 
 
Figure 1: Levels of the different microbial groups analized by qPCR in feces of infants from both experimental groups 
(SMOFLipid and INTRALipid) at 1, 15 and 30 days of life.* Denotes statistically significant (p<0.05) differences between both 
infant groups. 
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sole exception of the unusually high levels of Klebsiella 
observed in the SMOF Lipid group at 30 days of age 
(Figure 1). In both experimental groups the levels of 
most facultative anaerobes (Enterobacteriaceae, 
Enterococcaceae or lactobacilli) increased along the 
study period whereas those of strictly anaerobic 
microorganisms (Bacteroides and Bifidobacterium) 
remained with only minor modifications. In spite of the 
high inter-individual differences, when the results from 
both infant groups were compared (U Mann-Whitney 
test) no differences were found at the beginning (1
st
 
day of life) or after 15 days of intervention, but 
significantly higher (p<0.05) levels of Klebsiella were 
found in the SMOF Lipid group at the end of the 
intervention (30 days). This observation was in good 
agreement with a trend (not significant) towards higher 
levels of Enterobacteriaceae in the SMOF Lipid group. 
 
Figure 2: Concentration (mM) of the different short chain 
fatty acids (acetate, propionate and butyrate) as well as the 
sum of the three major SCFA, in feces of infants from both 
groups (SMOFLipid and INTRALipid) at 1, 15 and 30 days of 
life. 
With regard to SCFA (Figure 2) the concentration of 
acetate and total SCFA increased along time whilst that 
of propionate and butyrate did not show major 
changes. When both infants groups were compared no 
statistically significant differences (p>0.05) were found 
between the intervention and control groups. 
DISCUSSION 
The SMOF Lipid emulsion used in this study has 
been previously found to improve the lipid profile, to 
reduce oxidative stress and to decrease 
bronchopulmonary dysplasia in preterm infants under 
PN [7, 12]. Reducing the levels of oxidative stress in 
these preterm infants may result beneficial for reducing 
the risk of disease [13]. Moreover, decreasing the 
intestinal oxidative stress could also influence the gut 
microbiota composition [8]. However, almost no 
information is available to date on the impact of PN 
upon the gut microbiota establishment process and 
whether or not there is an effect of formulations with 
antioxidant properties. 
We found an increase over time in the levels of 
facultative anaerobes, such as Enterobacteriaceae, 
Enterococacceae or the group of Lactobacillus, in both 
groups of infants during the first month of life. This 
finding illustrates that facultative anaerobes trend to 
increase in the microbiota of the parenterally-fed 
preterm babies, whilst the levels of the strict anaerobes 
analyzed, Bacteroides and Bifidobacterium, remained 
stable. Moreover, our results show an effect of the 
experimental fat emulsion on the establishing gut 
microbiota. In spite of being a formula with a high 
potential for reducing the oxidative stress, the levels of 
strict anaerobes remained unchanged whilst those of a 
facultative anaerobes such as enterobacteria and 
specifically of microorganisms of the genus Klebsiella 
increased along treatment when compared with the 
control emulsion. Oxidative stress is known to produce 
reactive oxygen species that may react with sulphides 
and amines present in the gut lumen to form S-oxydes 
and N-oxydes, which in turn may be used as electron 
acceptors for anaerobic respiration by facultative 
anaerobes [14]. This may allow Enterobacteriaceae to 
out compete intestinal strict anaerobes, thus providing 
a reason for the increased levels of enterobacteria in 
the presence of oxidative stress in the gut [14]. 
However, in our study the oxidative status would be 
expected to be lower in the intervention group and, 
therefore, there is not a clear explanation for the 
increased levels of Klebsiella. 
To date, very few information is available regarding 
the effect of PN and antioxidants upon the neonatal 
microbiota. The potentially different effects of 
antioxidants, together with the complexity of the fat 
emulsion used containing also ?3 fatty acids with anti-
inflammatory potential, and the lack of knowledge on 
the effect of ?-tocopherol on the microbiota hinders the 
interpretation of our results. Nevertheless, our work 
stresses the need for studies monitoring the impact of 
early-life PN on the establishing intestinal microbiota.  
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